The CB2 Agonist β-Caryophyllene in Male and Female Rats Exposed to a Model of Persistent Inflammatory Pain.

cannabinoids formalin test persistent pain rats sex differences

Journal

Frontiers in neuroscience
ISSN: 1662-4548
Titre abrégé: Front Neurosci
Pays: Switzerland
ID NLM: 101478481

Informations de publication

Date de publication:
2020
Historique:
received: 24 04 2020
accepted: 21 07 2020
entrez: 5 10 2020
pubmed: 6 10 2020
medline: 6 10 2020
Statut: epublish

Résumé

Cannabinoids help in pain treatment through their action on CB1 and CB2 receptors. β-caryophyllene (BCP), an ancient remedy to treat pain, is a sesquiterpene found in large amounts in the essential oils of various spice and food plants such as oregano, cinnamon, and black pepper. It binds to the CB2 receptor, acting as a full agonist. Sex differences in the BCP-induced analgesic effect were studied by exposing male and female rats to a persistent/repeated painful stimulation. To simulate treatment of a repeated inflammatory condition, after the first formalin injection (FT1; 50 μl, 2.5%), rats received BCP

Identifiants

pubmed: 33013287
doi: 10.3389/fnins.2020.00850
pmc: PMC7461959
doi:

Types de publication

Journal Article

Langues

eng

Pagination

850

Informations de copyright

Copyright © 2020 Ceccarelli, Fiorenzani, Pessina, Pinassi, Aglianò, Miragliotta and Aloisi.

Références

J Cereb Blood Flow Metab. 2007 Jul;27(7):1387-96
pubmed: 17245417
Phytochemistry. 2001 May;57(1):65-9
pubmed: 11336262
Am Psychol. 2014 Feb-Mar;69(2):119-30
pubmed: 24547798
Br J Anaesth. 2008 Jul;101(1):59-68
pubmed: 18515270
Neuroendocrinology. 2009;89(4):424-40
pubmed: 19136814
Pain Pract. 2010 Sep-Oct;10(5):428-50
pubmed: 20492579
Molecules. 2019 Dec 27;25(1):
pubmed: 31892132
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S162-8
pubmed: 19540049
Eur Neuropsychopharmacol. 2014 Apr;24(4):608-20
pubmed: 24210682
Drug Alcohol Depend. 2014 Oct 1;143:22-8
pubmed: 25131716
J Nat Prod. 1992 Jul;55(7):999-1003
pubmed: 1402962
Curr Opin Investig Drugs. 2008 Jan;9(1):65-75
pubmed: 18183533
Eur J Pain. 2004 Oct;8(5):397-411
pubmed: 15324772
Sci Rep. 2016 Jan 08;6:18980
pubmed: 26742647
Physiol Behav. 2004 Feb;80(5):611-6
pubmed: 14984793
Brain. 2011 Apr;134(Pt 4):1127-39
pubmed: 21371995
Adv Pharmacol. 2017;80:437-475
pubmed: 28826543
Pain. 2000 May;86(1-2):25-32
pubmed: 10779657
Horm Behav. 2006 Jun;50(1):1-7
pubmed: 16423353
Neurosci Lett. 2011 Sep 8;502(1):5-9
pubmed: 21600961
Life Sci. 2013 Mar 19;92(8-9):476-81
pubmed: 22728714
Proc Natl Acad Sci U S A. 2006 Jan 17;103(3):696-701
pubmed: 16407142
Arch Med Res. 2019 Nov;50(8):518-526
pubmed: 32028095
J Agric Food Chem. 2003 Jul 16;51(15):4344-8
pubmed: 12848508
Physiol Behav. 1995 Sep;58(3):603-10
pubmed: 8587971
Horm Behav. 2010 Jun;58(1):100-10
pubmed: 19819241
Ann Ist Super Sanita. 2016 Apr-Jun;52(2):184-9
pubmed: 27364392
Eur J Neurosci. 2003 Jun;17(12):2750-4
pubmed: 12823482
Eur J Biochem. 1995 Aug 15;232(1):54-61
pubmed: 7556170
Curr Mol Pharmacol. 2009 Jan;2(1):134-9
pubmed: 20021453
Evid Based Complement Alternat Med. 2014;2014:596312
pubmed: 25097659
Neuropharmacology. 2017 Sep 15;124:105-120
pubmed: 28625720
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):440-50
pubmed: 19839933
J Neurosci Res. 2017 Jan 2;95(1-2):500-508
pubmed: 27870397
Curr Pharm Des. 2016;22(21):3237-64
pubmed: 26965491
CNS Neurol Disord Drug Targets. 2009 Dec;8(6):403-21
pubmed: 19839937
Curr Pharm Des. 2006;12(18):2319-25
pubmed: 16787257
Eur J Pharmacol. 2008 Jan 6;578(1):37-42
pubmed: 17905227
Pain. 1995 Aug;62(2):219-31
pubmed: 8545148
Eur J Pain. 2010 Jul;14(6):602-7
pubmed: 19948419
Behav Pharmacol. 2005 Sep;16(5-6):315-31
pubmed: 16148437
Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9099-104
pubmed: 18574142
Pain Physician. 2012 Jul;15(3 Suppl):ES111-8
pubmed: 22786450
Neuroscience. 2006 Jul 7;140(3):929-37
pubmed: 16580783
Molecules. 2019 Nov 21;24(23):
pubmed: 31766439
Br J Anaesth. 2001 Jul;87(1):3-11
pubmed: 11460811
J Neurosci Res. 2017 Jun;95(6):1271-1281
pubmed: 27452349
Pain. 1983 Jun;16(2):109-10
pubmed: 6877845
J Neurosci. 2006 May 24;26(21):5777-85
pubmed: 16723535

Auteurs

Ilaria Ceccarelli (I)

Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Paolo Fiorenzani (P)

Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Federica Pessina (F)

Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy.

Jessica Pinassi (J)

Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Margherita Aglianò (M)

Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Vincenzo Miragliotta (V)

Department of Veterinary Sciences, University of Pisa, Pisa, Italy.

Anna Maria Aloisi (AM)

Department of Medicine, Surgery and Neuroscience, University of Siena, Siena, Italy.

Classifications MeSH